Key facts
- Performr’s last known valuation is $2.7M (Apr 2025).
- It has raised $520K; the latest was Early Stage VC ($520K) in Apr 2025.
- Notable investors include SFC Capital, Andrei Petric, Dame Patricia Hewitt, Husayn Kassai, Jonathan O'Halloran — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Performr
- ·The full record, as it builds
Funding rounds
No funding rounds for Performr are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Performr
Developer of biomolecular performance tracking systems designed for physiological monitoring in athletic training. The company's platform integrates sensor units to measure metrics such as lactate thresholds, muscle oxygenation, hydration, oxidative stress, and glycogen levels, enabling athletes and fitness professionals to optimize training intensity, nutrition timing, and recovery strategies through molecular-level insights.
- Sector
- Healthcare
- HQ
- Liverpool, United Kingdom
- Founded
- 2024
- Employees
- 3
- Website
- performr.ai/
- Ownership
- Privately Held (backing)
Performr doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Performr shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Performr in its N-PORT filings yet. We sweep new filings monthly.